151 related articles for article (PubMed ID: 23508637)
1. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
[TBL] [Abstract][Full Text] [Related]
2. Correlation between genomic DNA copy number alterations and transcriptional expression in hepatitis B virus-associated hepatocellular carcinoma.
Huang J; Sheng HH; Shen T; Hu YJ; Xiao HS; Zhang Q; Zhang QH; Han ZG
FEBS Lett; 2006 Jun; 580(15):3571-81. PubMed ID: 16750200
[TBL] [Abstract][Full Text] [Related]
3. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
Roessler S; Long EL; Budhu A; Chen Y; Zhao X; Ji J; Walker R; Jia HL; Ye QH; Qin LX; Tang ZY; He P; Hunter KW; Thorgeirsson SS; Meltzer PS; Wang XW
Gastroenterology; 2012 Apr; 142(4):957-966.e12. PubMed ID: 22202459
[TBL] [Abstract][Full Text] [Related]
5. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.
Ip WK; Lai PB; Wong NL; Sy SM; Beheshti B; Squire JA; Wong N
Cancer Lett; 2007 Jun; 250(2):284-91. PubMed ID: 17126992
[TBL] [Abstract][Full Text] [Related]
6. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
7. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
[TBL] [Abstract][Full Text] [Related]
8. Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome.
Paradis V; Albuquerque M; Mebarki M; Hernandez L; Zalinski S; Quentin S; Belghiti J; Soulier J; Bedossa P
Gut; 2013 Jun; 62(6):911-9. PubMed ID: 22942238
[TBL] [Abstract][Full Text] [Related]
9. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
10. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ
Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
15. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
Katoh H; Ojima H; Kokubu A; Saito S; Kondo T; Kosuge T; Hosoda F; Imoto I; Inazawa J; Hirohashi S; Shibata T
Gastroenterology; 2007 Nov; 133(5):1475-86. PubMed ID: 17983802
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
17. Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.
Gu DL; Chen YH; Shih JH; Lin CH; Jou YS; Chen CF
World J Gastroenterol; 2013 Dec; 19(47):8873-9. PubMed ID: 24379610
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma.
Jia D; Wei L; Guo W; Zha R; Bao M; Chen Z; Zhao Y; Ge C; Zhao F; Chen T; Yao M; Li J; Wang H; Gu J; He X
Hepatology; 2011 Oct; 54(4):1227-36. PubMed ID: 21688285
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
[TBL] [Abstract][Full Text] [Related]
20. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
